Range
2.26 - 2.5
Vol / Avg.
205K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
73.8M
Payout Ratio
-
Open
2.46
P/E
-
EPS
-0.47
Shares
32.1M
Outstanding
32.1M
Total Float
23.9M
Sector: Health Care.Industry: Biotechnology
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-01
REV
Q3 2021Est.ActualSurprise
EPS-0.470
REV236.519K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Statera BioPharma Questions & Anwsers

Q

How do I buy Statera BioPharma (STAB) stock?

A

You can purchase shares of Statera BioPharma (NASDAQ: STAB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Statera BioPharma's (STAB) competitors?

Q

What is the target price for Statera BioPharma (STAB) stock?

A

There is no analysis for Statera BioPharma

Q

Current Stock Price for Statera BioPharma (STAB)?

A

The stock price for Statera BioPharma (NASDAQ: STAB) is $2.3 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Statera BioPharma (STAB) pay a dividend?

A

There are no upcoming dividends for Statera BioPharma.

Q

When is Statera BioPharma (NASDAQ:STAB) reporting earnings?

A

Statera BioPharma’s $Q4 earnings are confirmed for after-market on February 1, 2022.

Q

Is Statera BioPharma (STAB) going to split?

A

There is no upcoming split for Statera BioPharma.

Q

What sector and industry does Statera BioPharma (STAB) operate in?

A

Statera BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.